Mechanism of enhanced oral absorption of akebia saponin D by a self-nanoemulsifying drug delivery system loaded with phospholipid complex
Authors:
- 26 October 2018
- journal article
- research article
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 45 (1) , 124-129
Abstract
Akebia saponin D (ASD) exhibits a variety of pharmacological activities, such as anti-osteoporosis, neuroprotection, hepatoprotection, but has poor oral bioavailability. A self-nanoemulsifying drug delivery system loaded with akebia saponin D - phospholipid complex (APC-SNEDDS) (composition: Peceol: Cremophor® EL: Transcutol HP: ASD: phospholipid; ratio: 10:45:45:51:12.3, w:w:w:w:w) was first developed to improve the oral absorption of saponins and it was found to significantly enhance ASD’s oral bioavailability by 4.3 - fold (p < .01). This study was conducted to elucidate the mechanism of enhanced oral absorption of ASD by the drug delivery system of APC-SNEDDS. The aggregation morphology and particle size of ASD and APC-SNEDDS prepared in aqueous solutions were determined by transmission electron microscope and particle size analyzer, respectively. Stability of ASD and APC-SNEDDS in gastrointestinal luminal contents and mucosa homogenates were also explored. The differences of in situ intestinal permeability of ASD and APC-SNEDDS were compared. APC-SNEDDS reduced the aggregation size from 389 ± 7 nm (ASD) to 148 ± 3 nm (APC-SNEDDS). APC-SNEDDS increased the remaining drug in large intestine luminal contents from 47 ± 1% (ASD) to 83 ± 1% (APC-SNEDDS) during 4 h incubation. APC-SNEDDS provided an 11-fold increase in Ka value and an 11-fold increase in Peff value compared to ASD. In summary, APC-SNEDDS improved ASD’s oral bioavailability mainly by increasing membrane permeability, destroying self-micelles and inhibiting the intestinal metabolism.Keywords
Funding Information
- National Natural Science Foundation of China (30730113, 81703822)
- Administration of Traditional Chinese Medicine of Jiangsu Province (YB2015008)
- special funding for
- Guangxi BaGui Scholars
This publication has 36 references indexed in Scilit:
- Nanoemulsion loaded with lycobetaine–oleic acid ionic complex: physicochemical characteristics, in vitro, in vivo evaluation, and antitumor activityInternational Journal of Nanomedicine, 2013
- A novel drug–phospholipid complex enriched with micelles: preparation and evaluation in vitro and in vivoInternational Journal of Nanomedicine, 2013
- Saponins can perturb biologic membranes and reduce the surface tension of aqueous solutions: A correlation?Bioorganic & Medicinal Chemistry, 2012
- Mannosylated Lipid Nano-emulsions Loaded with Lycorine-oleic Acid Ionic Complex for Tumor Cell-specific DeliveryTheranostics, 2012
- Asperosaponin VI, A Saponin Component from Dipsacus asper Wall, induces Osteoblast Differentiation through Bone Morphogenetic Protein‐2/p38 and Extracellular Signal‐regulated Kinase 1/2 PathwayPhytotherapy Research, 2011
- Asperosaponin VI protects cardiac myocytes from hypoxia-induced apoptosis via activation of the PI3K/Akt and CREB pathwaysEuropean Journal of Pharmacology, 2010
- Enhancement of intestinal absorption of akebia saponin D by borneol and probenecid in situ and in vitroEnvironmental Toxicology and Pharmacology, 2010
- Protective roles of Asperosaponin VI, a triterpene saponin isolated from Dipsacus asper Wall on acute myocardial infarction in ratsEuropean Journal of Pharmacology, 2010
- Self-micelle formation and the incorporation of lipid in the formulation affect the intestinal absorption of Panax notoginsengInternational Journal of Pharmaceutics, 2008
- The Use of Lipid-Based Formulations to Increase the Oral Bioavailability of Panax Notoginseng Saponins Following a Single Oral Gavage to RatsDrug Development and Industrial Pharmacy, 2008